Dallas

Epidemiological Brief

As of 27 July 2026, Dallas is classified at LOW epidemic risk (composite score 13.7). Pertussis is the primary signal, with an incidence of 2.33 cases per 100,000 (36.6% adjusted score) — the highest single-disease contributor at this venue. COVID-19 activity is modest at 0.57 cases per 100,000, and influenza ILI prevalence stands at 1.1%, within seasonal norms. Mpox is detected at 0.11 cases per 100,000, with the adjusted impact attenuated by the mitigation factor. Travel-associated dengue cases are present at 0.05 cases per 100,000; local transmission is not endemic but imported cases warrant monitoring given World Cup fan travel. A hantavirus watch signal is active for the Dallas–Fort Worth region; while person-to-person transmission does not occur, outdoor venues should implement standard rodent-control measures and groundskeeping staff should receive risk communication. Measles data for Texas are not available in this surveillance cycle. Surveillance coverage is Low tier, limiting confidence in current estimates. Wastewater-based epidemiology (ATCP-73RE) is actively monitoring COVID-19 and influenza signals. No international arrivals were recorded in the current OpenSky cycle. Hot and dry conditions (32 °C, 51% humidity) elevate heat-related illness risk for outdoor gatherings. Recommended actions include pertussis outbreak surveillance, dengue prevention advisories for travellers, hantavirus rodent-control protocols, and heat illness prevention messaging at outdoor venues.

Model SCEME v3.1 · Updated July 27, 2026

Please consult a local doctor or pharmacist for guidance and medication.